includ
coronavirus
tend
vari
time
locat
recent
sequenc
variat
sarscov
first
epidem
phase
china
report
neutral
mutat
rate
sarscov
almost
constant
similar
known
rna
virus
protein
respons
virushost
receptor
recognit
display
extens
amino
acid
chang
addit
sequenc
analysi
isol
recent
sar
patient
china
shown
base
gene
base
gene
base
n
gene
isogen
submit
public
databas
date
back
first
epidem
spring
howev
even
minim
chang
could
render
exist
pcr
assay
ineffect
sarscov
reemerg
improv
abil
detect
sarscov
safe
reduc
risk
elicit
falseneg
result
caus
genom
sequenc
variat
establish
three
individu
realtim
rtpcr
assay
target
sequenc
chosen
use
follow
criteria
region
distribut
whole
genom
includ
nonstructur
polyprotein
gene
spike
glycoprotein
gene
tabl
region
highli
conserv
among
respect
sequenc
avail
public
sequenc
databas
region
suitabl
design
realtim
rtpcr
assay
design
primer
probe
amplicon
display
consider
homolog
virus
includ
human
cov
blast
search
avail
http
wwwncbinlmnihgovblast
assay
base
fluorogen
oligoprob
chemistri
use
activ
dna
polymeras
gener
specif
signal
produc
use
sybr
green
realtim
rtpcr
assay
success
run
appli
biosystem
realtim
pcr
system
appli
biosystem
foster
citi
ca
well
roch
lightcycl
roch
diagnost
gmbh
mannheim
germani
assay
design
onestep
rtpcr
reaction
run
ident
condit
respect
pcr
platform
system
allow
simultan
detect
differ
sarscov
region
singl
pcr
run
moreov
could
combin
three
assay
singl
tube
might
import
clinic
materi
limit
final
assay
compar
assay
publish
recent
commerci
avail
realtim
pcr
kit
realart
hpacoronaviru
lc
rt
pcr
reagent
artu
gmbh
hamburg
germani
optim
primer
probe
concentr
anneal
temperatur
reaction
condit
assay
follow
rtpcr
perform
appli
biosystem
platform
reaction
contain
probe
rtpcr
master
mix
qiagen
hilden
germani
pmol
primer
pmol
probe
quantitect
probe
rt
mix
rnasefre
water
ad
rna
use
cycl
condit
min
rt
reaction
min
inactiv
rt
activ
taq
dna
polymeras
cdna
denatur
follow
cycl
total
run
time
min
lightcycl
rtpcr
reaction
reaction
includ
rna
master
hybrid
probe
mix
roch
diagnost
gmbh
pmol
primer
pmol
probe
mn
oac
mmoll
rnasefre
water
ad
rna
use
cycl
condit
min
rt
reaction
initi
denatur
follow
cycl
total
run
time
min
combin
assay
set
ad
primer
probe
concentr
amount
water
reduc
accordingli
protocol
also
avail
robert
kochinstitut
homepag
wwwrkideinfektsarspcrprotocolpdf
human
gene
human
cyclophilin
gene
amplifi
ident
reaction
condit
sarscovspecif
assay
abi
platform
lightcycl
respect
act
amplif
control
evalu
sensit
sarscovspecif
assay
rtpcr
perform
repeatedli
serial
dilut
rna
extract
viral
rna
kit
qiagen
cultur
sarscov
defin
amount
genom
equival
ge
use
intern
standard
european
network
diagnost
import
viral
diseas
enivd
distribut
robert
kochinstitut
avail
http
www
rkideinfektsarsdatasheetpdf
result
shown
tabl
detect
limit
three
new
assay
ge
comparison
threshold
cycl
c
valu
show
new
assay
least
sensit
previous
describ
assay
commerci
avail
kit
combin
assay
singl
tube
target
three
differ
region
rna
templat
c
reduc
cycl
suggest
either
sensit
unchang
increas
attribut
combin
three
signal
lightcycl
subsequ
agaros
gel
analysi
optim
step
pcr
confirm
simultan
amplif
three
rtpcr
product
figur
onlin
avail
http
use
singl
combin
assay
analyz
bronchoalveolarlavag
fluid
sampl
suspect
sar
casepati
probabl
sar
patient
accord
robert
kochinstitut
case
definit
avail
http
wwwrkideinfektsarsaolgfalldefarsuupdf
sampl
posit
cyclophilin
control
sequenc
amplifi
parallel
agreement
previous
publish
assay
result
sarscov
detect
three
sampl
eight
probabl
sar
patient
without
explicit
differ
c
valu
individu
assay
singl
combin
assay
use
patient
seroposit
regard
confirm
sar
patient
respiratori
sampl
stool
sampl
taken
day
later
remain
probabl
patient
well
person
suspect
diseas
neg
rtpcr
moreov
patient
remain
seroneg
regard
unconfirm
sar
patient
addit
serum
sampl
patient
sarscov
infect
obtain
day
diseas
onset
analyz
geml
sarscovspecif
rna
detect
serum
sampl
even
serum
obtain
patient
day
diseas
onset
detail
descript
studi
publish
later
none
assay
display
crossreact
clinic
sampl
contain
human
cdna
blood
human
cov
influenza
virus
b
parainfluenzavirus
respiratori
syncyti
viru
rhinovirus
enterovirus
adenovirus
human
metapneumoviru
mycoplasma
pneumonia
chlamydia
pneumonia
pathogen
obtain
neither
fluoresc
signal
amplif
product
subsequ
agaros
gel
analysi
select
shown
onlin
figur
although
focus
onestep
rtpcr
decreas
handl
total
assay
time
three
realtim
rtpcr
assay
also
perform
twostep
rtpcr
includ
separ
cdna
synthesi
step
follow
pcr
final
use
appropri
readytous
master
mix
cycl
condit
omit
rt
step
singl
assay
combin
assay
also
use
extern
qualiti
assess
detect
sarscov
organ
enivd
assay
could
detect
sarscov
sampl
viru
load
rang
ge
two
isol
sarscov
per
millilit
sampl
without
falseposit
falseneg
result
applic
three
singl
assay
detect
sarscov
lead
higher
reliabl
neg
result
reflect
neg
outcom
three
independ
amplif
reaction
expens
approach
combin
assay
conclus
realtim
rtpcr
assay
describ
provid
fast
reliabl
tool
complement
improv
recent
introduc
techniqu
sar
diagnost
parallel
amplif
two
human
refer
gene
cyclophilin
confirm
neg
result
clinic
sampl
demonstr
amplifi
rna
separ
control
reaction
chosen
guarante
high
sensit
sarscov
detect
ge
sarscov
per
reaction
rtpcr
run
complet
h
depend
realtim
pcr
platform
case
small
amount
materi
emerg
situat
high
throughput
sampl
three
sarscovspecif
assay
combin
one
rtpcr
reaction
without
loss
sensit
furthermor
ambigu
diagnost
result
hospit
canada
recent
shown
target
three
differ
region
distribut
whole
genom
consider
reduc
risk
falseneg
result
caus
viru
sequenc
modif
emerg
infecti
diseas
wwwcdcgoveid
vol
juli
